Latest Breaking News On - Ampersand capital partners - Page 3 : comparemela.com

Genezen Secures $18 5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities

/PRNewswire/ Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5.

United statesNoord hollandConnor halversonSteven favaloroPrnewswire genezenDavid andersonContract developmentManufacturing organizationAmpersand capital partnersAmpersand capitalWith ampersandGeneral partner

Vaccine-trial focused P95 buys South African CRO OnQ Research

Vaccine-trial focused P95 buys South African CRO OnQ Research
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesRegion flamandeSouth africaThomas verstraetenCatherine lundAfrica onq researchIonq researchAmpersand capital partnersLatin america

P95, a leading vaccine-focused CRO, merges with South Africa-based CRO OnQ Research

P95 BV ("P95"), a portfolio company of Ampersand Capital Partners and leading provider of clinical and observational services to vaccine developers, has signed an agreement to merge OnQ Research ("OnQ") into P95. The transaction, which is subject to regulatory approval and scheduled to close before year end, furthers P95's goal of becoming the leading global, vaccine-focused CRO. P95 now has unparalleled expertise conducting research in emerging geographies on the infectious diseases which could

Noord hollandUnited statesThe netherlandsCatherine lundThomas verstraetenBenoit boucheGroupb strepIonq researchLatin americaNorth americanOperating partnerAmpersand capital partnersSouth africa basedInfectious diseasesClinical trialClinical research

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomBaden wübergUrs spitzEhab alramahyKamal badianiAlannah wheelerBiosynth groupHead of peptide divisionSenior vice presidentPeptide divisionManaging directorComplex chemicalsKey biologicsAmpersand capital partnersLife science

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pep

The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the product life cycle from discovery to commercialisation.STAAD, Switzerland (BUSINESS WIRE) Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pe.

United kingdomUrs spitzEhab alramahyKamal badianiAlannah wheelerHead of peptide divisionBiosynth groupSenior vice presidentPeptide divisionManaging directorComplex chemicalsKey biologicsAmpersand capital partnersLife science